ArticleJACC. Case reports2026
Pulmonary Embolism as the Initial Presentation of Klippel-Trénaunay Syndrome.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongenital vascular malformations are an under-recognized cause of venous thromboembolism in young adults, and their early identification carries important management implications. CASE SUMMARY: A 23-year-old man presented with intermediate-high risk pulmonary embolism (PE) and right ventricular dysfunction in the context of lifelong unilateral lower extremity varicosities. After classification by the PE response team, catheter-directed thrombolysis with EKOS ultrasound-assisted catheters achieved hemodynamic stabilization. Subsequent magnetic resonance venography identified extensive venous malformations, embryonic lateral vein persistence, and osseous involvement of the femoral medullary cavity, establishing a diagnosis of Klippel-Trénaunay syndrome (KTS) within the PIK3CA-related overgrowth spectrum. The patient was transitioned to long-term direct oral anticoagulation and referred for genetic counseling and PIK3CA mutation testing. DISCUSSION: KTS, a PIK3CA-related overgrowth spectrum disorder caused by somatic PIK3CA gain-of-function mutations, confers elevated lifelong venous thromboembolism (VTE) risk because of dysmorphic venous architecture and abnormal perforator veins. Recognition of this syndrome in young patients with VTE is essential, as it directs structured long-term surveillance, individualized thromboprophylaxis, and eligibility for emerging PI3K-AKT-mTOR targeted therapies. TAKE-HOME MESSAGES: Young patients with unprovoked PE and unilateral, early onset varicosities warrant evaluation for congenital vascular malformations. Identifying KTS enables multidisciplinary management and long-term VTE risk reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.